Massive stroke drug study shows Real-World results
Disease control
Completed
This study tested a clot-dissolving drug called non-immunogenic staphylokinase in over 23,000 adults who had an acute ischemic stroke within the last 4.5 hours. The goal was to see how safe and effective the drug is in everyday hospital practice. Researchers measured how many pat…
Sponsor: Supergene, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC